相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates
Pi-Xiao Wang et al.
NATURE MEDICINE (2017)
Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4
Guang-Nian Zhao et al.
NATURE MEDICINE (2017)
Tumor necrosis factor receptor-associated factor 5 (Traf5) acts as an essential negative regulator of hepatic steatosis
Ling Gao et al.
JOURNAL OF HEPATOLOGY (2016)
Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis
Mei Xiang et al.
JOURNAL OF HEPATOLOGY (2016)
DKK3 expression in hepatocytes defines susceptibility to liver steatosis and obesity
Lanfeng Xie et al.
JOURNAL OF HEPATOLOGY (2016)
Targeting TRAF3 signaling protects against hepatic ischemia/reperfusions injury
Junfei Hu et al.
JOURNAL OF HEPATOLOGY (2016)
TAK1 regulates hepatic lipid homeostasis through SREBP
S. Morioka et al.
ONCOGENE (2016)
Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling
Pi-Xiao Wang et al.
NATURE COMMUNICATIONS (2016)
The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling
Yan-Xiao Ji et al.
NATURE COMMUNICATIONS (2016)
Nonalcoholic Fatty Liver Disease A Systematic Review
Mary E. Rinella
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Current efforts and trends in the treatment of NASH
Vlad Ratziu et al.
JOURNAL OF HEPATOLOGY (2015)
Interferon Regulatory Factor 3 Constrains IKKβ/NF-κB Signaling to Alleviate Hepatic Steatosis and Insulin Resistance
Xin-An Wang et al.
HEPATOLOGY (2014)
Nonalcoholic Fatty Liver Disease, Hepatic Insulin Resistance, and Type 2 Diabetes
Andreas L. Birkenfeld et al.
HEPATOLOGY (2014)
TAK1-mediated autophagy and fatty acid oxidation prevent hepatosteatosis and tumorigenesis
Sayaka Inokuchi-Shimizu et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Periostin promotes liver steatosis and hypertriglyceridernia through dovvnregulation of PPARα
Yan Lu et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Dual-Specificity Phosphatase 14 (DUSP14/MKP6) Negatively Regulates TCR Signaling by Inhibiting TAB1 Activation
Chia-Yu Yang et al.
JOURNAL OF IMMUNOLOGY (2014)
Interferon regulatory factor 9 protects against hepatic insulin resistance and steatosis in male mice
Xin-An Wang et al.
HEPATOLOGY (2013)
The Dual-specificity Phosphatase DUSP14 Negatively Regulates Tumor Necrosis Factor- and Interleukin-1-induced Nuclear Factor-κB Activation by Dephosphorylating the Protein Kinase TAK1
Hao Zheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
Quentin M. Anstee et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Cell type-specific function of TAK1 in innate immune signaling
Adebusola A. Ajibade et al.
TRENDS IN IMMUNOLOGY (2013)
Inactivation of the Deubiquitinase CYLD in Hepatocytes Causes Apoptosis, Inflammation, Fibrosis, and Cancer
Kostas Nikolaou et al.
CANCER CELL (2012)
Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2
K. D. Copps et al.
DIABETOLOGIA (2012)
Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications
Kenneth Cusi
GASTROENTEROLOGY (2012)
The interaction of hepatic lipid and glucose metabolism in liver diseases
Lars P. Bechmann et al.
JOURNAL OF HEPATOLOGY (2012)
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Jorge Henao-Mejia et al.
NATURE (2012)
Insulin signaling to hepatic lipid metabolism in health and disease
Karla F. Leavens et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2011)
Will the Increased Prevalence of Nonalcoholic Steatohepatitis (NASH) in the Age of Better Hepatitis C Virus Therapy Make NASH the Deadlier Disease?
Mary E. Rinella
HEPATOLOGY (2011)
Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment
Briohny W. Smith et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
Human Fatty Liver Disease: Old Questions and New Insights
Jonathan C. Cohen et al.
SCIENCE (2011)
MAPK signalling in cellular metabolism: stress or wellness?
Helmuth Gehart et al.
EMBO REPORTS (2010)
Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical Implications
Elisa Fabbrini et al.
HEPATOLOGY (2010)
Mitogen-Activated Protein Kinase Signaling in the Heart: Angels Versus Demons in a Heart-Breaking Tale
Beth A. Rose et al.
PHYSIOLOGICAL REVIEWS (2010)
Dual-specificity phosphatases: critical regulators with diverse cellular targets
Kate I. Patterson et al.
BIOCHEMICAL JOURNAL (2009)
c-Jun N-Terminal Kinase Signaling in the Pathogenesis of Nonalcoholic Fatty Liver Disease: Multiple Roles in Multiple Steps
Yuzo Kodama et al.
HEPATOLOGY (2009)
Selective versus total insulin resistance: A pathogenic paradox
Michael S. Brown et al.
CELL METABOLISM (2008)
Insulin resistance, inflammation, and non-alcoholic fatty liver disease
Herbert Tilg et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2008)
Increasing GLP-1-induced β-cell proliferation by silencing the negative regulators of signaling cAMP response element modulator-α and DUSP14
Sonia Klinger et al.
DIABETES (2008)
Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases
D. M. Owens et al.
ONCOGENE (2007)
Inflammation and metabolic disorders
Goekhan S. Hotamisligil
NATURE (2006)
Critical roles of threonine 187 phosphorylation in cellular stress-induced rapid and transient activation of transforming growth factor-β-activated kinase 1 (TAK1) in a signaling complex containing TAK1-binding protein TAB1 and TAB2
P Singhirunnusorn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
DS Cai et al.
NATURE MEDICINE (2005)
A critical role for NF-kappa B in Gata3 expression and T(H)2 differentiation in allergic airway inflammation
J Das et al.
NATURE IMMUNOLOGY (2001)
Negative-feedback regulation of CD28 costimulation by a novel mitogen-activated protein kinase phosphatase, MKP6
F Marti et al.
JOURNAL OF IMMUNOLOGY (2001)
The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser307
V Aguirre et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
